In diabetic pregnancy, neonatal hypoglycemia (NH) is usually attributed to insufficient regulation of maternal glycemic control. Recent data suggest that maternal body mass index (BMI) could have an influence.
I
n the general obstetric population, maternal obesity is associated with an increased risk of perinatal complications such as pregnancy-induced hypertension (1), gestational diabetes mellitus (GDM) (1), cesarean section (1, 2) , miscarriage (3), preterm birth (4), neonatal macrosomia (1, 2) , birth defects (5), requirement of intensive care nursery admission (1) , and perinatal death (2) . As early as 1985, maternal obesity was reported to be associated with neonatal hypoglycemia (NH) (6) . In 2006, pregestational body mass index (BMI) has also been reported to be an independent predictor of NH in the general population, with a dose-response relationship (7) . In the Hyperglycemia and Pregnancy Outcome (HAPO) study, BMI categories higher than 22.6 kg/m 2 were positively associated with cord blood C-peptide, but significance was not reached for the prediction of NH (8) . More recently, in women with GDM, maternal obesity has been associated with NH with a linear trend for BMI categories (9) , but adjustment for potential confounders was not performed.
The aim of this study was to assess pregestational BMI as a predictor of NH in women with GDM and to analyze the influence of potential confounders. The prespecified hypothesis was that a positive association exists.
Subjects and Methods
We performed a retrospective study using the preexisting database of the Diabetes and Pregnancy Clinic of a tertiary care center (Hospital de la Santa Creu i Sant Pau, Barcelona). All pregnancies of women with GDM (singleton and multiple pregnancies) delivering in the hospital between January 1986 and December 2006 with a gestational age higher than 22 wk were analyzed.
Ethics
The study received specific approval of the Institutional Review Board.
Definitions
A universal two-step GDM diagnostic protocol according to the recommendations of the Third International Workshop Conference was used (10) . National Diabetes Data Group criteria (not Carpente and Coustan adaptation) were used for diagnosis (11) . Prepregnancy BMI was calculated using self-reported prepregnancy weight. Insulin treatment was started when capillary blood glucose (CBG) was at least 5.0 mmol/liter (90 mg/dl) fasting/preprandial and/or at least 6.7 mmol/liter (120 mg/dl) 1 h postprandial. Oral agents were not used. Weight increase during pregnancy was defined as the difference between weight recorded before delivery and self-reported weight before pregnancy. Glycemic control was assessed using mean blood glucose (MBG) and glycated hemoglobin (HbA1c). Weekly MBG was calculated as the weighted mean of self-monitored CBG (average of mean values before and 1 h postprandial). Data were collected in all women with GDM because the initiation of specialized care until delivery, irrespective of treatment (diet or diet plus insulin). MBG was calculated for each trimester after the mean of weekly MBG. HbA1c was measured monthly, and mean HbA1c was calculated for each trimester. Only third-trimester measurements were considered for both MBG and HbA1c because firstand second-trimester data were not available for all women. Gestational age was defined as complete weeks according to the date of last menstrual period, corrected after ultrasound when appropriate. Preterm birth was defined as birth before 37 complete weeks. Birth weight (BW) was classified according to gestational age, sex, and singleton/multiple pregnancy using Spanish reference growth charts (12) . Large for gestational age (LGA) newborns were defined as those with BW higher than the 90th percentile, and small for gestational age (SGA) as those with BW lower than or equal to the 10th percentile. Abnormal Apgar was defined as a 1-min Apgar score below 7. Intensified glycemic control during labor and delivery was instituted in 1996 to help prevent NH (13) . The protocol is common to all diabetic pregnant women, independent of the type of diabetes, the treatment during pregnancy, and of the type of delivery. After delivery, early feeding was promoted whenever feasible. For noncomplicated newborns, the protocol of neonatal glucose monitoring started immediately after birth and included frequent measurements (eight in the first 24 h and two in the second day). The number of glucose measurements was increased when clinically required. Measurements were performed in heel blood glucose and using a reflectance meter (models with low influence of hematocrit, changed over time). NH was defined using Cornblath and Reisner's criteria (14) , which take into consideration both BW and prematurity. Newborns were considered to be hypoglycemic when two or more glucose values were lower than the cutoffs (Ͻ1.11 mmol/liter in the first 48 h for newborns that are either preterm or weigh Յ2500 g, Ͻ1.67 mmol/liter in the first 48 h for newborns that are both term and weigh Ͼ2500 g, or Ͻ2.22 mmol/liter after 48 h for all newborns). Respiratory distress was defined as any type of respiratory distress (including transient tachypnea) requiring treatment. Hypertension was defined as any type of hypertension during pregnancy or in the first week after delivery, chronic or pregnancy-induced (systolic blood pressure Ն140 mm Hg and/or diastolic blood pressure Ն90 mm Hg) with or without proteinuria.
Statistical analysis
The study was designed as exploratory, and sample size was not calculated.
Statistical analysis was performed using SPSS version 18.0. Bivariate analyses were performed to compare characteristics of pregnancies with and without NH: 2 , Student's t test, and Mann-Whitney U test when appropriate.
Logistic regression analyses used NH as the dependent variable. A backward method was used, and thus, all predictive variables included by the software in the final model will be accepted as significant predictors. In addition to maternal BMI, we considered other variables as potential predictors of NH [gestational age and glucose values at the diagnostic oral glucose tolerance test (OGTT), delay between diagnosis and treatment, third-trimester mean CBG and HbA1c, insulin treatment, weight increase during pregnancy, multiple pregnancy, and newborn sex]. Newborn sex was included as a predictor of NH because an association with male sex has been reported (15) . Other variables were considered as intermediate steps between maternal BMI and NH because they have been associated with NH and they are more prevalent in women with GDM. These included cesarean section (H. Ortega-Senovilla, personal communication), maternal hypertension (16), SGA and LGA newborns (17, 18) , abnormal Apgar (19) , and preterm birth (20) . Because the association of BMI with NH could be the consequence of its impact on these perinatal complications, we performed logistic regression analyses both including and not including these potential intermediate steps. The relationship of BMI with NH was explored using BMI as a qualitative variable (Ͻ20, 20 -24.99, 25.00 -29.99, and Ն30 kg/m 2 ); if the association was nonlinear, BMI categories were grouped according to the observed odds ratio (OR). Glycemic control during delivery was not included as a potential predictor because information was available only in a subgroup of women. As a sensitivity analysis, we performed the logistic regression analyses with and without potential intermediate causes in the subgroup of singleton births.
In the descriptive analysis, missing data were individually excluded from each variable.
Significance was set at a bilateral P Ͻ 0.05.
Results
Two thousand ninety-two newborns (1925 singletons and 167 from multiple pregnancies, 85% of total GDM deliveries in the period) had information on NH and were included in the analysis. The prevalence of NH was 3% (n ϭ 63).
The number of glycemic measurements in the neonates was similar in both groups: 11 (range six to 23) in newborns with NH and nine (range two to 23) in those not suffering from NH. In the bivariate analysis, pregnancies with and without NH differed in prepregnancy BMI, third-trimester MBG, insulin treatment, hypertension, cesarean section, and abnormal Apgar at 1 min (Table 1) . Differences were in the expected direction with the exception of third-trimester MBG that was lower in mothers of newborns with NH.
In the logistic regression analysis using BMI as a Table 2 ). Additional predictive variables are displayed in these tables.
In the sensitivity analysis including only singleton births, prepregnancy maternal BMI continued to be included in the The main strength of this study is that it is the first time that this question is specifically addressed in women with GDM while adjusting for potential confounders. In addition, the association is strong with an OR higher than 2, and results are consistent in singleton pregnancies and the whole population.
The criteria used for NH diagnosis can be viewed as a weakness of this study because the most recent guidelines are not followed (21) . We have used Cornblath criteria because the diagnosis of NH with these criteria was available for the whole series. The fact that a laboratory measurement was not used for confirmation of NH is another potential weakness. Heel CBG measurement using reflectance meters were used to allow prompt treatment and to avoid newborn anemization (hematocrit is usually not high in infants of GDM mothers delivered in this center). However, both facts should have decreased the statistical power of our analysis (Cornblath vs . recent criteria of NH should lead to a lower number of events, and CBG measurement of infant glycemia should lead to more imprecision). Thus, it is remarkable the clear positive association between pregestational BMI and NH herein reported. The lack of adjustment by glycemic control during labor can be viewed as another limitation. Cornblath criteria are roughly similar to the definition of clinical hypoglycemia in the HAPO study. Thus, the prevalence of 3% herein reported should be compared with the 1.8% figure of clinical hypoglycemia in the HAPO study (22) . The higher rate in the current study has to be attributed to the fact that all women have a GDM diagnosis, whereas in the HAPO study, women with normal glucose tolerance were also included. In addition, the two-step approach (limited sensitivity) and criteria used for diagnosis (National Diabetes Data Group) in the current study imply a more severe glycemic derangement.
These results are in agreement with the report of Roman et al. (9) in women with GDM describing a linear increase of NH with BMI category but where no adjustment for potential confounders was performed. The results also fit with data in a general obstetric population where pregestational BMI has been positively associated with NH (7) and with cord C-peptide (8) . Remarkably, in the article of Callaway et al. (7) , the association in a general obstetric population was not linear with a threshold 2 ). We can only speculate on the mechanisms underlying the association; in fact, no suggestion was made in the above-mentioned articles. Obese subjects display higher levels not only of blood glucose but also of free fatty acids (23) and amino acids (24) . Amino acids and free fatty acids from triglycerides reach the fetus and act as ␤-cell secretagogues and influence growth in fetal life (25) . Thus, we suggest that maternal overnutrition in obesity can influence fetal insulin secretion through increased availability of lipids, amino acids, and glucose. The data herein reported are adjusted by glycemic values in the diagnostic OGTT as well as by third-trimester HbA1c and MBG, so that the described influence of BMI on NH is independent of maternal glucose.
In the logistic regression analysis including potential intermediate steps, gestational age at diagnosis, maternal hypertension, and delivery by cesarean sections are positive predictors of NH in addition to prepregnancy BMI. The last two will be in accordance with published reports (16) or current information (H. Ortega-Senovilla, personal communication), whereas gestational age at diagnosis could point to a delayed diagnosis underlying the association. HbA1c displayed a negative association with NH both in the analysis with and without intermediate steps. In the analysis without intermediate steps, the negative association of HbA1c was combined with a positive association of the number of abnormal points in the diagnostic OGTT, so that the overall effect of maternal glycemia can be viewed of positive. However, in the analysis including intermediate variables, the only association of NH with variables related to maternal glycemia is a negative association with HbA1c. It cannot be mediated through abnormal BW (21) (the analysis is adjusted by SGA/LGA), and we do not have an explanation for it. In a recent review on the relationship of antepartum maternal HbA1c on pregnancy outcomes in women with GDM, the association with BW is described as erratic (26) .
The association between increased maternal BMI and NH seems well established in the general population. Although the information is more limited for GDM, the association goes in the same direction, supporting the existence of this relationship.
We conclude that pregestational BMI is an independent predictor of NH in this group of women with GDM.
